147 related articles for article (PubMed ID: 25787914)
1. Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma.
Li Z; Stölzel F; Onel K; Sukhanova M; Mirza MK; Yap KL; Borinets O; Larson RA; Stock W; Sasaki MM; Joseph L; Raca G
Leukemia; 2015 Oct; 29(10):2113-6. PubMed ID: 25787914
[No Abstract] [Full Text] [Related]
2. Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.
Pastoret C; Houot R; Llamas-Gutierrez F; Boulland ML; Marchand T; Tas P; Ly-Sunnaram B; Gandemer V; Lamy T; Roussel M; Fest T
Leuk Lymphoma; 2017 Apr; 58(4):1008-1012. PubMed ID: 27659839
[No Abstract] [Full Text] [Related]
3. Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.
Cervera N; Carbuccia N; Garnier S; Guille A; Adélaïde J; Murati A; Vey N; Mozziconacci MJ; Chaffanet M; Birnbaum D; Gelsi-Boyer V
Leukemia; 2016 Apr; 30(4):966-70. PubMed ID: 26202927
[No Abstract] [Full Text] [Related]
4. Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.
Kashofer K; Gornicec M; Lind K; Caraffini V; Schauer S; Beham-Schmid C; Wölfler A; Hoefler G; Sill H; Zebisch A
Leuk Lymphoma; 2018 Feb; 59(2):501-504. PubMed ID: 28633614
[No Abstract] [Full Text] [Related]
5. Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study.
Wheler JJ; Janku F; Naing A; Li Y; Stephen B; Zinner R; Subbiah V; Fu S; Karp D; Falchook GS; Tsimberidou AM; Piha-Paul S; Anderson R; Ke D; Miller V; Yelensky R; Lee JJ; Hong DS; Kurzrock R
Cancer Res; 2016 Jul; 76(13):3690-701. PubMed ID: 27197177
[TBL] [Abstract][Full Text] [Related]
6. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
[TBL] [Abstract][Full Text] [Related]
8. Somatic ASXL1 p.R693X mutation identified by next generation sequencing in isolated myeloid sarcoma involving the mediastinum.
Fang L; Cui Y; Mi Y; Ru K; Sun Q; Qin T; Xu Z; Wang J; Xiao Z
Curr Med Res Opin; 2020 Jun; 36(6):1003-1007. PubMed ID: 32286099
[No Abstract] [Full Text] [Related]
9. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
11. Case report: Rare myeloid sarcoma development following renal transplantation with KRAS and DNMT3A gene mutations.
Wu D; Lu X; Yan X; Gao R
Diagn Pathol; 2021 Aug; 16(1):82. PubMed ID: 34465355
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations for laboratory standardization of next generation sequencing in hematological malignancies].
Xu CS; Li XQ; Liu HX; Li CB; Chen Z; Cai JP; Peng MT
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3204-3208. PubMed ID: 31694113
[TBL] [Abstract][Full Text] [Related]
13. Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.
Werstein B; Dunlap J; Cascio MJ; Ohgami RS; Fan G; Press R; Raess PW
J Mol Diagn; 2020 Mar; 22(3):338-345. PubMed ID: 31866570
[TBL] [Abstract][Full Text] [Related]
14. Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.
Sánchez R; Ayala R; Martínez-López J
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185671
[TBL] [Abstract][Full Text] [Related]
15. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.
Antony-Debré I; Duployez N; Bucci M; Geffroy S; Micol JB; Renneville A; Boissel N; Dhédin N; Réa D; Nelken B; Berthon C; Leblanc T; Mozziconacci MJ; Favier R; Heller PG; Abdel-Wahab O; Raslova H; Latger-Cannard V; Preudhomme C
Leukemia; 2016 Apr; 30(4):999-1002. PubMed ID: 26316320
[No Abstract] [Full Text] [Related]
18. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
19. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
Friedman K; Resnick MB; Safran H
R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
[TBL] [Abstract][Full Text] [Related]
20. The impact of sequencing on diagnosis and treatment of malignant melanoma.
Castiglione R; Ihle MA; Heydt C; Schultheis AM; Merkelbach-Bruse S; Mauch C; Büttner R
Expert Rev Mol Diagn; 2016; 16(4):423-33. PubMed ID: 26822148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
